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Introduction 
Long-chain polyunsaturated fatty acids (LC-PUFA), especially 
docosahexaenoic acid (C22:6n-3, DHA) and arachidonic acid 
(C20:4n-6, AA), may affect the development of the infant brain as well as 
the infant growth pattern both before and after delivery [1,2]. These LC-
PUFAs accumulate in the brain alongside foetal body fat, particularly 
during the third trimester of pregnancy and the first few months post-
term. They are found especially in the synaptic membranes of neurons 
of the cortical and midbrain grey matter [1,3] in areas responsible for 
sensory integration, motor control and attention [4]. During the third 
trimester the foetus receives approximately 50 mg/(kg*day) of total n-3 
LC-PUFA and 400 mg/(kg*day) of total n-6 PUFA [5-7]. AA seems 
to accumulate to a larger extend than DHA in the foetal brain until 
around the time of expected delivery; but subsequently DHA is the 
dominant LC-PUFA [5,8]. 
Metabolic maturation of cells and organs is believed to take place in 
the late stage of gestation [9,10] and in the early months after delivery 
at which time the foetal brain undergoes several structural changes. 
Neural differentiation, formation and adaptation of synaptic functions 
as well as glial cell production and myelination take place alongside 
neuronal regression and conversion of the foetal cortical subplate 
into a mature cortical structure. This transition is believed to mediate 
the simultaneous change in infant neuro-behaviour, e.g. in motor 
control from primitive reflexes and jerky movements to smooth and 
volitional motion [5,11]. Preterm delivery carries a risk of disrupting 
these processes, and apparently healthy, late-preterm infants (defined 
as infants born with a gestational age of 34-36 weeks) can experience 
long-term developmental problems such as difficulties with attention 
span, language skills and visuo-spatial motor function [11]. 
Human milk displays large individual and regional variations in the 
content of LC-PUFA, most pronouncedly in DHA, which also varies 
during the course of the day reflecting the content of the individual 
meals of the mother [12]. Individual factors such as maternal lifestyle, 
dietary intake and supplementation are determinants for the presence 
of individual PUFA in the milk [1]. LC-PUFA has been shown to 
decrease during the lactation period, and breast-milk of mothers with 
preterm delivery has been shown to have a higher content of LC-PUFA 
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Abstract
Background: The supply of long-chain polyunsaturated fatty acids (LC-PUFA) during pregnancy and early 
lactation has been shown to affect cognitive development in preterm infants, but the effect on early neurodevelopment 
of late-preterm infants has not yet been examined. 
Aim: To examine the fatty acid composition of late-preterm human milk and identify possible associations between 
infant LC-PUFA status and perinatal as well as 1-year neurobehavioral outcomes.
Methods: Mother’s milk and erythrocytes (RBC) were sampled from 53 Danish late-preterm infants (33-36 weeks 
of gestation) 1 week and 1 month after delivery, and 3 months corrected age. Fatty acid composition was determined 
by gas-liquid chromatography. Neurodevelopmental outcomes were assessed by the Nicu Network Neurobehavioral 
Scale (NNNS) at 1 week and 1 month and the Bayley Scales (BSID-III) at 1 year corrected age. 
Results: We found that breast-milk content of arachidonic acid (AA) and docosahexaenoic acid (DHA) was similar 
to reported fatty acid compositions of term human milk. Infant RBC-AA decreased from 1 week to 1 month of age and 
the size of the decrease was associated with better NNNS-scores at 1 month, specifically on regulation (p=0.03). 
Infant RBC-AA at 1 month was also associated with a lower 1-year corrected age BSID-III score of receptive language 
(p=0.05) and fine motor development (p=0.03). Infant RBC-DHA did not decrease significantly after delivery and was 
not associated with any of the developmental outcomes. 
Conclusion: Breast-milk LC-PUFA content was reflected in the RBC LC-PUFA status of the infant. Early RBC-AA 
status was associated with both early and long-term neurobehavioral development, but not in a consistent way.
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[13-16], but the fatty acid composition of late-preterm breast-milk is 
not well described [1]. 
To our knowledge, measures of early sensory integration such as 
stimulus habituation, level of arousal and quality of general movements 
(QoM) have only been sparsely evaluated as endpoints for LC-PUFA 
effects or as confounders for later neurodevelopment [17-21]. The aim 
of the current prospective cohort study was to investigate LC-PUFA 
status and development in late-preterm infants and to see to what extent 
measures of early sensory integration and later cognitive performance 
was associated with infant LC-PUFA status. We hypothesize that late-
preterm infants may depend on DHA for optimal neurodevelopment.
Materials and Methods
Study population
In the period May 2011 to July 2012, 53 infants born at gestational 
age of 33.1-36.6 weeks were recruited within a few days after delivery 
(max 7 days) from the neonatal ward of the Department of Paediatrics, 
Holbaek University Hospital, which is a minor urban hospital in the 
provincial part of Zealand, Denmark. Gestational age at delivery was 
the only inclusion criterion. Exclusion criteria were: severe peripartum 
asphyxia (standard base excess <-16 or transfer to a highly specialized 
hospital for cooling treatment), severe septicaemia, known serious 
malformations, distance from residence to the hospital <2 h transport, 
severe psychosocial challenges (e.g. early forced removal of the infant) 
and major linguistic barriers in the communication with the parents. 
The study was approved by The National Committee on Health 
Research Ethics in Region Zealand (SJ-198) and the Danish Data 
Protection Agency, and was conducted in accordance with the 
Declaration of Helsinki. Written informed consent was obtained from 
both infant custody holders at enrolment.
Clinical examinations
The recruited infants were examined four times during the first 
year of life; at 1 week and 1 month after delivery and at 3 and 12 months 
corrected age (after expected date of delivery). The 1-year follow-up 
examinations were carried out from June 2012 to July 2013.
Samples of infant blood and mother’s milk were collected at the first 
three visit, and the parents filled out a questionnaire about lactation 
(extend and duration), formula feeding, maternal and child health, 
lifestyle, socioeconomic factors and dietary supplementations as well 
as maternal food-frequency topics. Between the visits the parents were 
asked to keep a log of infant feeding mode on a weekly basis and in 
case of any formula feeding to indicate the ratio of formula to breast-
milk as well as the brand name of the formula. Exclusive breastfeeding 
was defined as <1 formula meal per week and <1 breast-milk meal per 
day was defined as exclusive formula feeding. Furthermore, the parents 
were asked to log the health status and any medication of the child. The 
project physician and the parents reviewed the logs at every outpatient 
visit to intercept and record any possible discrepancies. The parents 
returned the completed logs at the third visit.
Developmental testing
Infant neuro-developmental status was assessed at 1 week and 1 
month after delivery using the Nicu Network Neurobehavioral Scale 
(NNNS) [10]. NNNS is a neurobehavioral performance test that covers 
neurological maturation including motor maturity, tone, posture, 
general autonomic signs of stress and tolerance to stimulation, reflexes, 
social- and self-regulatory competencies [10]. NNNS scores have 
been shown to correlate with outcome measures on the Bayley Scales 
of Infant Development (BSID) [21,22]. NNNS is designed for use 
within gestational age 30 to approximately 46-48 weeks and normative 
preterm and healthy full term samples are available in the test manual 
[23]. For this study, we selected 3 out of 13 available summary scores as 
described in the Statistics section below. 
Infant developmental milestones were recorded in the period 
between 3 and 12 months corrected age. Developmental outcomes at 12 
months corrected age were determined by the third version of the BSID 
(III, Danish version 2009, Pearson Assessment, San Antonio, USA). 
BSID is the long-standing gold standard for infant global developmental 
testing and a proven method for detecting developmental anomalies. 
BSID evaluates cognitive, language and motor skills. Receptive and 
expressive language skills are evaluated separately and combined into 
an aggregate score and the same applies to fine motor and gross motor 
skills [24].
Testing conditions for both NNNS and BSID were selected to 
create the best possibilities for the infants to stay relaxed and attentive. 
All examinations took place in a quiet ambulatory room without wall 
decorations. The curtains were closed and the computer screen turned 
off, and for the NNNS test electric lights were off to keep the infants 
from focusing on lights and shadows. Both tests were performed 
halfway between meals if possible and the infants were examined in 
the presence of only one parent to avoid distraction. Furthermore, we 
aimed to begin the NNNS examination while the infant was still asleep. 
All examinations were video recorded, and performed by the lead 
investigator after proper training by a certified instructor [10].
Blood sampling and fatty acid analysis
At each visit, blood was drawn in 2-mL lithium-heparin vials. 
Erythrocytes (RBC) were immediately isolated by centrifugation at 
2300×G for 5 minutes at 4°C. Plasma was removed and the RBC were 
washed three times in 0.9% NaCl with 1 mM EDTA at pH 7.4, re-
suspended 1:1 in an isotonic NaCl-solution with a final concentration 
of 0.1% butylated hydroxytoluen (VWR – Bie & Berntsen, Herlev, 
Denmark) and stored under N2 at -80ºC for a maximum of 3 months.
RBC fatty acid composition was determined as previously described 
[25]. In brief: RBC were haemolysed in redistilled water, and the lipids 
were extracted by the Folch procedure [26]. Fatty acid methyl esters 
were produced from the extracted RBC lipids using a BF3-catalyzed 
method [27] and extracted with heptane and analysed by gas-liquid 
chromatography on an Agilent 6890 Series II chromatograph (Agilent 
Inc., Santa Clara, California, USA) equipped with a flame ionization 
detector and a SP2380 capillary column (length 60 m; internal diameter 
0.25 mm and film thickness 0.2 µm from Supelco Inc, Pennsylvania, 
USA) [28]. Fatty acid peaks were identified using a standard mixture 
(Nu-Check Prep, Elysian, MN), and data are given as mass-% based on 
peak-area relative to the sum of all peak areas corrected for differences 
in detector-response. The average intra-assay coefficient of variation 
was 3.0% for linoleic acid (LA), 0.4% for eicosapentaenoic acid and 
0.2% for AA and DHA, and the inter-assay coefficient of variation were 
4% for LA, 0.6% for eicosapentaenoic acid and 0.4% for AA and DHA. 
Milk sampling and fatty acid analysis
A 50 mL breast-milk sample was collected between 5 and 8 a.m. in 
the last days up to each examination using an electric hand-held breast 
pump (Medela Swing, Medela AG, Baar, Switzerland). Many mothers 
could not deliver the 50 mL at once, especially at the first sampling, 
so they were allowed up to three consecutive mornings to collect 
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the sample. Mothers were instructed to freeze their milk samples 
immediately after pumping in their home freezer, and in case they had 
to do the pumping on more than one morning, to keep the samples 
in separate containers. The mothers transported the milk samples 
from their home freezer to the clinic in an UV-proof black cooler bag 
containing a freezing element with capacity to keep the bag content 
frozen for the duration of the drive to the clinic. Immediately upon 
arrival, milk samples were placed at -18ºC until further processing. 
Within a few days (≤7 days), the samples were thawed in a 20ºC water 
bath; sub-samples were pooled and gently mixed. The samples were 
aliquoted in 0.5 mL containers and 0.1% butylated hydroxytoluen in 
ethanol was added to aliquots for fatty acid analysis. The samples were 
then blown with N2 and kept at -80ºC until analysis. Samples were 
analysed within 3 months from collection. 
The breast-milk samples were freeze-dried for analysis of fatty 
acid composition. The freeze-dried material was mixed with 1 mL 
of heptane containing 0.4 mg/mL of internal standard (C12:1 cis11 
triacylglycerol from NuChekPrep Inc, Elysian MN, USA). Methylation 
was carried out as a two-step procedure based on Jenkins [29] with 
modifications. Base-catalysed methylation carried out by addition of 
0.2 mL 25% sodium methoxide, followed by incubation at 50°C for 10 
min. After cooling 1.5 mL of a 10% methanolic HCl was added and 
the samples were incubated at 90°C for 30 min. After cooling 3 mL 
10% K2CO3 was added, tubes were centrifuged and the heptane layer 
was isolated. Separation of the fatty acid methyl esters was carried 
out on an Agilent 6890 gas chromatograph with a flame ionization 
detector and a Restek 2560 capillary column (length 100 m, internal 
diameter 0.25 mm and film thickness 0.20 µm from Restek, Bellefonte, 
Pennsylvania, USA). The temperature program started at 100°C for 5 
min, followed by an increase of 3°C/min to 140°C, another increase 
of 20°C/min to 160°C, where it was kept for 20 min followed by an 
increase of 12°C/min to 220°C, which was then kept for 15 min after 
which it was increased at 8°C/min to a final temperature of 240°C for 
8 min. The carrier gas was helium at a constant flow of 1 mL/min. 
The individual peaks were identified by use of external standards (37 
component mix from Supelco, Belafonte, USA and GLC 469 standard 
from NuChekPrep Inc., Elysian, MN, USA) and quantified by use of 
the internal standard. The total sum of fatty acids was calculated as g/L 
milk and the content of individual fatty acids was expressed as mass-% 
fatty acids. The coefficients of variation for LA, AA and DHA were 4%, 
5% and 5%, respectively. 
Statistics
The statistical analyses were performed by IBM SPSS Statistics 
software (version 20.0). Data are presented as frequencies or mean 
± SD. Students t-test was used for group comparisons e.g. gender 
differences and participants vs. non-participants (excluded infants, 
those refusing to participate and those lost to follow-up). Correlations 
between exposures, outcomes and possible covariates were calculated 
using the non-parametric Spearman’s test. Assumption of normality 
was tested by Shapiro-Wilk’s test and visual inspection of histograms, 
and by examining the residual plots of the final univariate linear 
models.
Univariate general linear models were used to test associations 
between LC-PUFA and developmental scores. The models were built 
by backwards-stepwise exclusion (p<0.05) of possible covariates: 
gender, gestational age at delivery, maternal education, socioeconomic 
status (composite score of education and occupation as defined by 
The Danish National Centre for Social Research) maternal psychiatric 
disorder (e.g. depression), multiple pregnancy, smoking in pregnancy, 
maternal multiparity and age at neurological assessment (days). None 
of these covariates were correlated (Spearman p>0.05). Furthermore, 
maternal smoking was also tested as a potential covariate for breast-
milk LC-PUFA levels. 
To avoid multiple testing we carefully selected the measures of 
breast-milk and infant RBC LC-PUFA as well as the NNNS scores to be 
used in analyses of association. In order to do that we used information 
about breastfeeding from questionnaires and interviews and data on 
the fatty acid composition of the breast-milk and infant RBC samples 
to determine which samples to use in our correlation and association 
analyses. The individual variation in breast-milk DHA (1.03% at 1 week 
and 1.35% at 1 month) exceeded the changes over time, i.e. between the 
means at 1 week and 1 month (0.19%), so we estimated that the mean 
DHA of all three samples would give the most accurate description 
of infant DHA intake during the breastfeeding period. We tested this 
assumption by comparing the mean after 1 month with the combined 
mean (by t-test); and as we found no difference, we chose the combined 
mean as our independent variable in the subsequent analyses. The same 
rationale applied to breast-milk AA.
Infant RBC LC-PUFA levels are expected to be associated with 
brain accumulation of AA and DHA [30] so we considered infant RBC 
levels the best proxy for brain LC-PUFAs and chose RBC as our main 
focus in the analysis of association with infant neurodevelopment. The 
following rationale was applied in selecting which RBC samples to use 
in our analyses: Because of the approximately 3-months turnover of the 
RBC, the 1-week infant RBC sample reflects the LC-PUFA supply during 
pregnancy and does not reflect supply from breastfeeding. The 1-month 
sample reflects the LC-PUFA supply from 32 weeks of gestation to 4 
weeks post-term, and thus covers 8-12 weeks of extrauterine enteral 
feeding depending on the infant’s gestational age at delivery, whereas 
the sample taken at 3 months corrected age in teory should reflect the 
entire early feeding period. However, as descriptive statistics showed 
an increasing uniformity of the 3 months samples and a discrepancy 
between the 3 months sample and the previous two samples and as an 
increasing number of children stopped breastfeeding, we considered 
the sample taken at 1 month post-term to be the best measure of infant 
LC-PUFA uptake from breast-milk. 
NNNS generates 13 summary scores, some of which measure 
primarily physiological instability or neurological damage, which was 
outside the scope of this study (excitability, lethargy, stress/abstinence, 
handling, hyper-/hypotonia [31]). To find the scores most suitable to 
use for comparison of development between infants, we reviewed the 
internal correlation of scores over time (by Spearman’s test), number 
of missing values, and normal distribution as well as how the scores 
reflected hypotheses in previous studies in the LC-PUFA field. Three 
out of the remaining 7 summary scores were used in our analyses: 
quality of movement (QoM), regulation and arousal (which was 
strongly negatively correlated with habituation, r=-0.42, p=0.006). 
QoM summarizes motor maturity, control and activity as well as the 
ability to perform smooth movements without startles, tremors or 
jitters. Regulation evaluates the combined scores of attention, motor 
and psychological activity and the infant’s capacity to regain comfort 
with and without examiner assistance. Arousal is a measure of the 
infant’s overall level of motor activity and irritability, fuss and cry in 
response to handling, as well as the state of arousal reached during the 
examination [32]. Higher scores in all three variables indicate a higher 
degree of neuro-maturation. 
We examined if RBC LC-PUFA status during the perinatal period 
was associated with the three NNNS measures at delivery and at 1 
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month post-delivery by correlation analysis and univariate linear 
regression models adjusted for gender and gestational age. BSID-III 
scores at 1 year corrected age (cognitive, receptive language, expressive 
language, fine motor and gross motor scale scores) were also tested 
against AA and DHA in breast-milk and infant RBC. To determine 
whether neuro-developmental status at delivery excerts a confounding 
influence on developmental status in later infancy, we included the 
NNNS measures as covariates in the final models for the BSID-III 
outcomes.
Due to the explorative nature and the small sample size of this 
study, performing a rigorous correction for multiple testing (e.g. by 
Bonferroni) would increase the risk of type-II errors considerably. 
We therefore chose not to correct for multiple testing, but to report 
the p-values of our analyses and to discuss the potential relevance of 
findings with p-values <0.05.
Results 
The inclusion rate was 69% (Figure 1). The characteristics of 
the included mothers and infants (Table 1) differed only from non-
participants by slightly younger mothers (29±5 years vs. 31±4 years, 
p=0.048). The rate of loss to follow-up was 9% (n=5) and the lost 
infants differed from the remaining infants by a higher rate of maternal 
psychiatric disorder (p=0.015), although this was caused by only one 
twin mother (n=2). 
Sixteen infants (30%) were never exclusively breastfed and 
introduction of complementary feeding was initiated at a mean age 
of 147±25 days corresponding to 116±24 days post-term. Infants who 
were breastfed at 3 months corrected age differed from those who were 
not by the frequency of maternal smoking in pregnancy (50% smokers 
in the non-breastfeeding group vs. 5.4% in the breastfeeding group, 
p<0.001) and maternal smoking was correlated with low socioeconomic 
status (r=0.29, p=0.035).
Fatty acid composition of breast-milk and infant RBC
The LC-PUFA composition of the breast-milk and the infant RBC 
samples are shown in Table 2. There was a significant 26% decline 
(p<0.001) in breast-milk DHA during the first month, but there was 
no significant difference between the fatty acid composition of the milk 
samples at 1 month after delivery and at 3 months corrected age. The 
mean levels of AA and DHA in the combined samples were 0.61±0.13 
mass-% for AA and 0.66±0.28 mass-% for DHA. The RBC content of 
LA and DHA in the infants increased over time, whereas that of AA 
decreased (all changes p<0.05). 
Overall, the correlations between breast-milk and infant RBC were 
positive for both AA and DHA (Table 3). Breast-milk and RBC-LA 
were only correlated at 1 month after delivery. There was no associaton 
between gestational age at delivery and infant RBC-DHA, AA or LA, 
although AA showed a trend towards a negative association (B=-
0.07±0.032, p=0.051). There was a decrease in the variance for infant 
RBC-DHA and AA at 3 months corrected age, and the correlations 
between the infant RBC samples at 1 month and 3 months as well as 
between breast-milk and infant RBC at 3 months were not significant 
except for AA (Table 3), which may be due to the increase in formula 
feeding frequency after 1 month of age. 
LC-PUFA and NNNS
Paired t-tests between the NNNS scores at 1 week and 1 month 
revealed that regulation and arousal increased over time, but no 
increase was seen in QoM (Table 5A). QoM at 1 week and 1 month 
of age were found to correlate (Spearman r=-0.31, p=0.02), whereas 
no correlations were seen for regulation (r=0.02, p=0.90) and arousal 
(r=0.12, p=0.39). There was no gender difference in the NNNS scores 
at any of the examinations.
There were no significant correlations (Spearman) between the 
levels of AA or DHA in infant RBC at 1 month of age and any of the 
NNNS scores. There was also no correlation between the changes 
in infant RBC-AA and DHA between 1 week and 1 month and the 
corresponding changes in the NNNS scores, but arousal at 1 month of 
age tended to correlate negatively with the change in infant RBC-AA 
(r=-0.30, p=0.050). The relationships between infant RBC LC-PUFA 
status and the NNNS neuro-developmental measures at 1 week and 
1 month were also examined by analyses adjusted for gender and 
gestational age at delivery (Table 5B). At 1 week of age we found no 
significant associations between the NNNS scores and RBC LC-
PUFA, but infant RBC-AA was found to be positively associated with 
regulation 1 month after delivery (Table 5B). This association was also 
significant after adjusting for AA status at 1 week (p=0.028). Adjusting 
for regulation at 1 week of age had no impact on this association. Infant 
RBC-DHA at 1 month or the change over time in RBC-DHA was not 
associated with any of the NNNS scores at 1 month. The changes in 
NNNS scores between the two examinations and the corresponding 
changes in RBC-AA and DHA were not associated.
LC-PUFAs and BSID-III
T-tests revealed a gender difference in the score on the cognitive 
scale with girls having 14% higher scores than boys (p=0.045). No other 
gender differences were found in the BSID-III scores. The correlations 
between the breast-milk sample LC-PUFA means and infant RBC 
LC-PUFA at 1 month of age versus BSID-III outcomes were generally 
not significant, except for breast-milk AA, which correlated positively 
with the cognitive scale score (p=0.002, r=0.46). The mean AA for all 
breast-milk samples was also associated with the cognitive score in 
models adjusted for gender (B=8.69±3.08, p=0.007). Furthermore, 
RBC-AA was associated with the receptive language and fine motor 
scale score in univariate adjusted GLM models, but in this it was an 
inverse association (Table 6). Inclusion of infant NNNS scores at 1 
week as covariates did not change the associations between RBC LC-
Figure 1: Participants. Flow of inclusion and exclusion, and of visits and sample 
collection.
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PUFA and BSID-III scores. These models did not show any significant 
associations between the NNNS scores at 1 week and the BSID-III 
scores at 1 year, except for QoM which was associated with expressive 
language (B=1.35±0.63, p=0.040).
Discussion
Our most important findings were that AA and DHA in the 
breast-milk and infant RBC samples were significantly associated and 
that both early and later neurodevelopment of late-preterm infants 
was not related to RBC-DHA, but related to infant RBC-AA status. 
The fatty acid composition of the breast-milk samples demonstrated 
a considerable individual variation. Compared to the present study, 
previous Danish and Dutch studies [26,34] found lower breast-milk 
levels of AA and DHA, and similar levels of LA in mothers of term 
infants with low-average fish intake. These studies also reported a 
reduction in the breast-milk content of AA and DHA from delivery 
Male (n=32) Female (n=21)
% yes Mean ± SD Range % yes Mean ± SD Range
Post-mentrual age, days 248 ± 8 233 – 259 248 ± 8 231 – 258
Birth weight, g 2503 ± 456 1346 – 3235 2655 ± 530 1455 – 3930
Mother's age, yrs 30 ± 6 20 – 40 27 ± 3 20 – 31
Pre-pregnancy weight, kg 66 ± 13 49 – 95 72 ± 13 47 – 98
Pre-pregnancy BMI, kg/m2 24.6 ± 4.6 18.9 – 37.1 24.8 ± 4.1 16.7 – 32.9
Weight gain in pregnancy, kg 14 ± 6 1 – 29 14 ± 5 6 – 21
Smoking in pregnancy 15.6 19.0
Multiple birth 31.3 19.0
Low socioeconomic status1 40.6 28.6
Maternal psychiatric disorder 25.0 42.9
Any breastfeeding, wks 33 ± 22 0 – 60 26 ± 21 0 – 60
Exclusive breastfeeding, wks 6 ± 5 0 – 12 7 ± 6 0 – 12
Prop. of breastfeeding, % 1 week 1 month 3 months2 1 week 1 month 3 months2 
Exclusive breastfeeding 31.3 28.1 62.5 38.1 38.1 61.9 
Combination 62.5 62.5 6.3 57.1 52.4 9.5
Exclusive formula 6.3 6.3 28.1 4.8 4.8 23.8
Missing 0 3.1 3.1 0 4.8 4.8
Data are given as mean ± SD and range minimum-maximum or percent as appropriate.  
1As defined by The Danish National Centre for Social Research 
2Corrected age
Table 1: Characteristics of the study population by infant gender.
 Sampling time 1 week 1 month 3 months corrected age Effect of sample no.
Infant age (days) 9.40 ± 3.03 31.90 ± 4.53 93.80 ± 5.76
R
B
C
n = 50 n = 46 n = 45
Fatty acid p (explained var)
LA 6.42 ± 0.91 8.74 ± 1.23 9.34 ± 1.18  ↑ 0.00 (56.8%)
AA 18.44 ± 1.76 16.99 ± 1.72 17.34 ± 1.47  ↓ 0.00 (17.2%)
DHA 6.88 ± 0.96 6.59 ± 0.87 7.03 ± 1.04 ↑ 0.03 (7.8%)
Total SFA 38.78 ± 1.46 37.89 ± 2.26 36.07 ± 1.67
Total MUFA 15.76 ± 1.02 16.70 ± 1.17 15.99 ± 1.43
Total n-3 PUFA 8.17 ± 1.15 8.21 ± 1.14 9.43 ± 1.24
Total n-6 PUFA 32.03 ± 2.02 32.93 ± 2.07 28.20 ± 1.35
Total PUFA 40.20 ± 2.37 41.14 ± 2.59 37.63 ± 1.69
n-6/n-3 PUFA ratio 3.99 ± 0.61 4.08 ± 0.58 3.05 ± 0.46
n = 44 n = 37 n = 29 p (explained var)
B
re
as
t-m
ilk
LA 10.76 ± 2.78 10.78 ± 1.95 11.13 ± 1.78    0.85 (0.6%)
AA 0.72 ± 0.17 0.52 ± 0.11 0.49 ± 0.11  ↓ 0.00 (56.3%)
DHA 0.74 ± 0.24 0.55 ± 0.27 0.64 ± 0.61    0.09 (8.3%)
Total SFA 44.74 ± 6.36 44.52 ± 4.78 43.80 ± 7.34
Total MUFA 39.51 ± 4.74 40.36 ± 3.86 40.85 ± 6.16
Total n-3 PUFA 2.59 ± 0.56 2.43 ± 0.70 2.55 ± 1.06
Total n-6 PUFA 12.08 ± 2.85 11.87 ± 1.96 12.11 ± 1.84
Total PUFA 14.67 ± 3.16 14.30 ± 2.40 14.65 ± 2.38
n-6/n-3 PUFA ratio 4.76 ± 1.10 5.16 ± 1.23 5.35 ± 1.90
Total fat (g/L) 34.6 ± 13.0 36.8 ± 11.7 30.6 ± 15.7
Data are given as mean±SD. LA=linoleic acid. AA=arachidonic acid. DHA=docosahexaenoic acid. 
SFA=saturated fatty acid. MUFA=monounsaturated fatty acid. PUFA=polyunsaturated fatty acid.
Table 2: Fatty acid composition in breast-milk and infant erythrocytes.
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to later stages of breastfeeding as well as an increase in the LA content 
[26,34]. Two Swedish studies on moderately-late preterm infants have 
also shown lower breast-milk levels of all three PUFAs [5,34], but a 
Spanish study found a considerably higher breast-milk levels of LA 
and AA levels, which were similar to the ones we observed [13]. The 
Spanish study did not include any breast-milk samples from late-stage 
lactation, but found that the DHA level increased over the first few 
weeks of lactation from initially 0.1% to 0.5% of the fatty acids [13]. 
The individual levels of both LA, AA and DHA in the RBC from 
the infants in the present study tended to be higher than that reported 
in more preterm populations [35-37], but resembled reported levels in 
RBC from both Danish [25] and American term infants [38,39]. The 
fatty acid composition of the infant RBC at 1 month of age was found 
to reflect that a considerable proportion of the infants were to some 
extent formula fed. All formulas on the Danish market contain LA, AA 
and DHA, although in varying amounts. The infants in our cohort were 
supplemented according to local guidelines with either a hydrolysed 
formula with high levels of LC-PUFA (Nutramigen-1 Lipil from 
Mead Johnson Nutrition) or standard formulas with moderate levels 
of LC-PUFA (e.g. NAN-1 from Nestlé or Allomin-1 from Semper). 
Breastfeeding mothers were potentially biased by their participation in 
the study to consume more fish and the high levels of LC-PUFA in the 
RBC may therefore be influenced by a higher-than-average LC-PUFA 
intake. A larger variation in the RBC LC-PUFA levels would have been 
better in terms of showing relationships between LC-PUFA status and 
neurodevelopment. 
A few previous studies have found that LC-PUFA composition 
of breast-milk/formula, maternal RBC and umbilical cord blood was 
associated with the early QoM in term infants [18–20] as well as in 
preterm infants (born in gestational week 24-36) [17,35], but the 
investigated LC-PUFA indices and ratios vary and the results are not 
very consistent. None of these studies have tested the infants as shortly 
after delivery as in the present study. However, we found no associations 
between LC-PUFA and the NNNS scores at 1 week. Our results did 
however show a positive association between infant RBC-AA (both at 
1 week and 1 month) and the NNNS score for regulation at 1 month 
of age. RBC-AA at 1 month of age was also found to be negatively 
associated with BSID-III receptive language and fine motor abilities at 
1 year corrected age, but no associations were observed for DHA. The 
lack of a significant associations between breast-milk or RBC-DHA 
and developmental outcome are in line with previous observations 
[40–42], although some studies have demonstrated beneficial effects of 
DHA on psychomotor development in both term and preterm infants 
[35,43–45]. A recent Swedish study found significant correlations 
between breast-milk AA and developmental outcomes at 40 weeks 
gestational age in preterm infants (born in gestational week 24-36) 
using the Brazelton Neonatal Behavioral Assesment Scale, which is 
very similar to the NNNS [16]. Another Swedish cohort study [34] of 
moderately preterm infants found positive associations between both 
AA and DHA in infant blood and global developmental outcomes 
at 18 months of age, but negative associations with n-6 PUFA and 
the n-6/n-3 PUFA ratio. The observed assocition between AA and 
language skills is in accordance with some previous studies of term 
infant showing negative associations between LC-PUFA intake or 
status and language development [26,46], but other studies found no 
effect [47,48]. The previous studies have primarily focused on the effect 
of supplementation with fish oil, DHA or DHA+AA. Recent large 
randomized controlled trials have shown a negative effect of maternal 
DHA supplementation in pregnancy on the language development 
in girls born at term [48], but a positive effect of post-delivery DHA 
Sampling time LA AA DHA
Breast-milk 
 vs.  
RBC
1 week NS p=0.04r=0.33
p=0.03
r=0.35
1 month p=0.00r=0.51
p=0.00
r=0.51
p=0.00
r=0.48
3 months1 NS p=0.03r=0.44 NS
Data are given as Spearman’s correlation coefficient (r) and p-value. NS=non-
significant. LA=linoleic acid. 
AA=arachidonic acid. DHA=docosahexaenoic acid. RBC=erythrocyte.
1Corrected age 
Table 3: Correlations between fatty acids in breast-milk and infant erythrocytes 
(RBC).
Male (n=30) Female (n=18)
Mean ± SD Range Mean ± SD Range
Cognitive scale score 12.0 ± 3.1 5 - 18 13.7 ± 2.1 10 - 17
Receptive scale score 8.9 ± 2.4 5 - 15 10.3 ± 3.1 6 - 16
Expressive scale score 10.5 ± 2.0 7 - 15 10.8 ± 1.9 8 - 16
Fine motor scale score 11.5 ± 2.4 8 - 16 12.7 ± 3.6 7 - 19
Gross motor scale score 8.7 ± 2.0 4 - 13 9.6 ± 2.8 3 - 15
Data are given as mean±SD and range (min-max).
Table 4: Developmental scores on Bayley Scales of Infant Development-III at 1 
year corrected-age.
A 1 week 1 month Change over time (∆ NNNS)
Mean ± SD Range Mean ± SD Range Mean ± SEM p n
QoM (3.81±0.78) 4.51 ± 0.41 3.00–5.17 4.48 ± 0.47 3.20–5.33 -0.05 ± 0.10 0.616 51
Regulation (5.0 ± 0.82) 5.65 ± 0.76 4.00–7.67 5.91 ± 0.83 3.81–7.23  0.27 ± 0.16 0.087 50
Arousal (4.16 ± 0.81) 3.46 ± 0.71 2.00–5.00 4.02 ± 0.68 2.29–5.43  0.58 ± 0.13 <0.001 51
B B  ±  SE p n B  ±  SE p n
46
A
A
QoM  0.00 ± 0.04 0.95 50  0.09 ± 0.05 0.080
Regulation  0.00 ± 0.07 0.99 50  0.23 ± 0.08 0.006 46
Arousal -0.06 ± 0.07 0.42 50 -0.13 ± 0.08 0.097 46
D
H
A
QoM  0.12 ± 0.06 0.06 50  0.10 ± 0.08 0.214 46
Regulation  0.04 ± 0.12 0.74 50  0.01 ± 0.14 0.958 46
Arousal  0.10 ± 0.12 0.40 50  0.08 ± 0.12 0.511 46
Data are given as mean  ±  SD and range, or parameter estimates (B)  ±  SE, p-values and n.  
All analyses are adjusted for gender and gestational age at delivery.
Table 5: Quality of movement (QoM), regulation and arousal at 1 week to 1 month after delivery (A) and their association with infant erythrocyte arachidonic acid (AA) and 
docosahexaenoic acid (DHA) (B)
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supplementation in preterm girls and no effect in boys [48,49]. 
The individual variation in DHA status at a given time was 
substantial, but it may take a considerably larger population to detect 
a potential effect of DHA on development. The lack of an association 
between DHA and development could also be due to a lack of n-3 
PUFA deficiency in the infants in the study. DHA and AA are usually 
measured as mass-% and ”compete” with each other as well as other 
PUFA with respect to RBC-incorporation, it is therefore possible that 
the seemingly negative effect of AA to some extent is caused by reduced 
presence of other PUFAs. The functional domains affected by RBC-
AA in this study (regulation, receptive language and fine motor skills) 
share a relation with the periventricular midbrain structures and the 
cerebellum, which are where the accretion of LC-PUFA mainly occur 
in late gestation. DHA accumulates in the brain at a later stage than 
AA [4] and the impact of early sub-optimal DHA supply may only be 
found in later stages of neurodevelopment. 
As described above, infant RBC-AA was linked to 
neurodevelopmental outcomes in both early and later infancy, but in 
an inconsistent way. We are not able to say if the early benefit and later 
negative effect in this study are linked or if they are due to chance, as we 
were unable to show an association between early neurodevelopmental 
maturity and psychomotor scores at 1 year, except for an association 
between QoM at 1 month of age and the expressive language score of 
BSID-III. It is possible that a larger sample size would have enabled us 
to demonstrate more associations between early neuromaturation and 
later psychomotor development. 
Neurodevelopment both early in infancy and at 1 year was 
assessed with clinically validated tests. Our three selected NNNS 
summary scores (QoM, regulation and arousal) were related to what 
we wanted to examine (motor control, stimulus tolerance and level 
of alertnes) and gave reliable scores (i.e. were available in most of 
the infants, normally distributed and internally correlated). These 
functional domains also relate to brain areas associated with perinatal 
LC-PUFA accretion. QoM in early infancy has been addressed quite 
often in previous studies and is used as a measure of motor maturity in 
several other developmental tests (e.g., Prechtl, ENIGMA or Peabody). 
Regulation is a measure of the infants ability to tolerate stimulation and 
is closely related to habituation, which is often used as a measure of the 
ability to inhibit responses to a continued stimulus (tactile, visual or 
auditory). However, the evaluation of infant habituation in the NNNS 
test requires that the test is started with a sleeping infant, and in an 
outpatient setting such as ours, this is not always possible. BSID-III is 
a global developmental test, designed to contrast developmental delay 
and normal psychomotor development. It is considered the golden 
standard for developmental testing of infants and is widely used in 
studies of LC-PUFA influences on early childhood development, but 
some researchers have pointed out that it may not be ideal for detecting 
minor variations within normality [47,50-54]. 
The main limitations of the present study is the small sample 
size. We planned for a considerably larger study, but were not able to 
include more participants within the given time frame. This was mainly 
explained by a 40% drop in the local preterm infant delivery rate [55] 
due to a temporary discontinuation of a longstanding government 
subsidy for infertility treatment. Furthermore, the exposures (2) and 
outcomes (8) were tested multiple times against each other. Formal 
Bonferroni correction (p<0.003) would yield all of our tests insigificant, 
but the Bonferroni method is known for its very conservative approach 
and we found it un-suited for our explorative purpose [56]. We realize 
that much caution must be applied in the interpretation of our results, 
but they can be used for the planning future studies of LC-PUFA and 
infancy development. Depending on the desired outcome, and given 
the parameter estimates in this study, the required sample size in such 
studies  would have to be considerably larger, e.g. 111 and 214 for QoM 
and arousal at 1 month of age, respectively, and 345 for BSID-III at 1 
year.
Due to the observational nature of the study we cannot exclude 
residual confounding although we did adjust for various maternal 
variables, but the possibility of other confounders such as maternal 
stimulation of the infant or genetic influences remain. Furthermore, 
only 62% (n=33) were able to exclusively breastfeed and there was 
a highly significant difference in the frequency of maternal smokers 
between those still breastfeeding at 3 monts corrected age and those 
with a short breastfeeding duration. This is a potential bias in our study, 
as it resulted in a higher representation of breast-milk samples from 
women of higher socioeconomic status. The associations between the 
RBC samples and the developmental outcomes were, however, not 
affected by maternal smoking. There was a slight difference in maternal 
age between the participants and the non-participants, but this 
difference is probably not a clinically relevant factor. However, we did 
find a minor, but significant, difference in the occurrence of maternal 
psychiatric disorder between the infants lost to follow-up and those 
remaining in the study, but this were caused by only one twin mother. 
Maternal psychiatric disorder was a statistically significant covariate in 
the associations between infant LC-PUFA status and receptive language 
BSID-III score, but because of the small sample size, the impact of this 
difference is uncertain. The overall attendance at outpatient controls 
and follow-up was good and the consistency of our data is good. The 
internal validity of our study is also good as all examinations were 
performed by one investigator and all samples handled by one lab 
technician. Furthermore, we did not only rely on breast-milk samples, 
but also analyzed infant RBC fatty acid composition, which gives a 
more stable measure of LC-PUFA accretion. 
Conclusion
In this relatively small cohort, late-preterm breast-milk LC-PUFA 
content was high compared to other preterm studies. The infants 
were primarily healthy with appropriate weight for gestational age 
and only minor developmental variations, but certain aspects of 
early neuromaturation and development at 1 year corrected age was 
associated in an inconsistent way with AA in breast-milk and infant 
RBC in the perinatal period. Our results must be approached with 
caution, but they warrent further testing with precise tests of sensory 
integrity in larger cohorts to properly investigate effects of perinatal 
LC-PUFA-status on early neurodevelopment in healthy late-preterm 
infants.
Infant erythrocyte (n=44)
AA DHA
B
S
ID
-II
I
Cognitive scale score B=-0.28 ± 0.28, p=0.341 B=-0.58 ± 0.45, p=0.212
Receptive scale score B=-0.53 ± 0.26, p=0.053 B=-0.43 ± 0.42, p=0.313
Expressive scale score B=-0.14 ± 0.16, p=0.404 B=-0.32 ± 0.32, p=0.325
Fine motor scale score B=-0.70 ± 0.30, p=0.031 B=-0.58 ± 0.52, p=0.271
Gross motor scale score B=0.19 ± 0.22, p=0.38 B=-0.44 ± 0.42, p=0.30
Data are given as parameter estimates (B ± SD) and p-value (p) from multiple 
regression analysis adjusted for 1 Gender; 2 Gender, corrected-age; 3 Gender, 
maternal psychiatric disorder; 4 Multiple birth; and 5 Multiple birth, corrected age
Table 6:  Univariate associations between infant erythrocyte arachidonic acid (AA) 
and docosahexaenoic acid (DHA) at 1 month of age and developmental outcomes 
at 1 year corrected age measured with Bayley Scales of Infant Development-III.
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